Adami G, Montanari F, Fassio A, Pollastri F, et al. Increase in Serum DKK1 Levels Attenuates the Anabolic Response to Romosozumab in Postmenopausal Osteoporosis. J Bone Miner Res 2025 Aug 19:zjaf110. doi: 10.1093.
PMID: 40827677